![Eric Keller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Eric Keller is the founder of Response Pharmaceuticals, Inc., founded in 2020, holding the title of Co-Chairman & Chief Executive Officer since 2020.
Mr. Keller currently holds the position of President & Director at Noveome Biotherapeutics, Inc. since 2022.
Postes actifs de Eric Keller
| Sociétés | Poste | Début |
|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | President | 16/11/2022 |
Response Pharmaceuticals, Inc.
 Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutic development company focused on developing treatments for weight management and metabolic disease | Directeur Général | 01/01/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Health Technology |
Response Pharmaceuticals, Inc.
Response Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage therapeutic development company focused on developing treatments for weight management and metabolic disease | Health Technology |
